Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 13/20 | 0.50 |
| ▸ | ACHE | P22303 | 12/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | EPOR | P19235 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5936595 | 0.92 | KDM4E (0.51) | BCHEACHEKDM4EMEN1ALDH1A1 | |
| SCHEMBL5936607 | 0.86 | KDM4E (0.49) | BCHEACHEKDM4EMEN1ALDH1A1 | |
| SCHEMBL5936618 | 0.83 | NR4A2 (0.52) | BCHEKDM4EMEN1ALDH1A1KMT2A | |
| SCHEMBL1122837 | 0.78 | PPARG (0.51) | KDM4EMEN1ALDH1A1KMT2AATM | |
| SCHEMBL1123335 | 0.77 | LPAR1 (0.52) | ACHEKDM4EMEN1ALDH1A1KMT2A | |
| SCHEMBL1122838 | 0.76 | PTGES (0.48) | KDM4EMEN1ALDH1A1KMT2AATM | |
| SCHEMBL1122672 | 0.76 | PKM (0.63) | BCHEACHEKDM4EMEN1KMT2A | |
| SCHEMBL1123230 | 0.75 | LPAR1 (0.48) | MAOB | |
| SCHEMBL27638146 | 0.75 | PTGES (0.50) | BCHEACHEKDM4EMEN1ALDH1A1 | |
| SCHEMBL1122692 | 0.75 | LPAR1 (0.55) | HDAC1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060160894-A1 | Benzamides as ppar modulators | LABORATORIOS S.A.L.V.A.T.,S.A. (ES) | 2006-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160894-A1 | Benzamides as ppar modulators | PPARD, PPARA, PPARG | BCHE 520/4885ACHE 3017/4885KDM4E 2065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.